Developmental Signalling Laboratory, The Francis Crick Institute, London, UK.
Division of Cell Biology, MRC Laboratory of Molecular Biology, Cambridge, UK.
Nat Rev Mol Cell Biol. 2023 Dec;24(12):876-894. doi: 10.1038/s41580-023-00638-3. Epub 2023 Aug 18.
The transforming growth factor-β (TGFβ) family are a large group of evolutionarily conserved cytokines whose signalling modulates cell fate decision-making across varying cellular contexts at different stages of life. Here we discuss new findings in early embryos that reveal how, in contrast to our original understanding of morphogen interpretation, robust cell fate specification can originate from a noisy combination of signalling inputs and a broad range of signalling levels. We compare this evidence with novel findings on the roles of TGFβ family signalling in tissue maintenance and homeostasis during juvenile and adult life, spanning the skeletal, haemopoietic and immune systems. From these comparisons, it emerges that in contrast to robust developing systems, relatively small perturbations in TGFβ family signalling have detrimental effects at later stages in life, leading to aberrant cell fate specification and disease, for example in cancer or congenital disorders. Finally, we highlight novel strategies to target and amend dysfunction in signalling and discuss how gleaning knowledge from different fields of biology can help in the development of therapeutics for aberrant TGFβ family signalling in disease.
转化生长因子-β(TGFβ)家族是一组进化上保守的细胞因子,其信号转导在生命的不同阶段和不同的细胞环境中调节细胞命运决策。在这里,我们讨论了早期胚胎中的新发现,这些发现揭示了与我们对形态发生素解释的最初理解相反,强大的细胞命运特化如何源自信号输入的嘈杂组合和广泛的信号水平范围。我们将这些证据与 TGFβ 家族信号在青少年和成年期组织维持和体内平衡中的新作用进行了比较,涵盖了骨骼、造血和免疫系统。从这些比较中可以看出,与强大的发育系统相反,TGFβ 家族信号的相对较小干扰在生命的后期会产生有害影响,导致异常的细胞命运特化和疾病,例如癌症或先天性疾病。最后,我们强调了靶向和纠正信号转导功能障碍的新策略,并讨论了如何从不同的生物学领域汲取知识来帮助开发治疗疾病中异常 TGFβ 家族信号转导的方法。